Appointment of KMP Key Managerial Personnel

As per Section 2(51) of the Companies Act, 2013, KMP includes the Chief Executive Officer (CEO), Managing Director (MD), Manager, Company Secretary (CS), Whole-Time Director (WTD), Chief Financial Officer (CFO), and any other officer designated as KMP by the Board.

KMP is the broader definition under Section 2(51) covering all key personnel. Whole-time KMP refers to those KMPs who dedicate their full time to the company and cannot hold office in more than one company simultaneously (except subsidiaries) as per Section 203(3).

Section 203 of the Companies Act, 2013, read with Rule 8 of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, mandates the appointment of KMP for specified classes of companies.

An MD is entrusted with substantial powers of management and must be a director. A Manager manages the whole affairs under the Board’s supervision, but need not be a director. A company cannot appoint both the MD and the Manager simultaneously as per Section 196(1).

Yes, KMPs are explicitly included in the definition of ‘Officer in Default’ under Section 2(60) of the Companies Act, 2013. They are personally liable for non-compliance penalties imposed on the company.

As per Rule 8, every listed company (regardless of paid-up capital) and every unlisted public company with paid-up share capital of ₹10 Crore or more must appoint whole-time KMPs (MD/CEO/Manager or WTD, plus CS and CFO independently). Private companies with ₹10 Crore+ capital must appoint a whole-time CS under Rule 8A.

Under Rule 8A (w.e.f. 01.04.2020), every private company with a paid-up share capital of ₹10 Crore or more must mandatorily appoint a whole-time Company Secretary. Other KMP positions are optional unless the private company voluntarily chooses to appoint them.

Yes, a private company can voluntarily appoint an MD even if not mandated by Section 203. However, once appointed, all provisions of the Companies Act relating to MD appointment, tenure, and filings must be complied with, including Form DIR-12.

If the capital drops below ₹10 Crore, the company may not be legally required to fill any new vacancy. However, existing KMPs usually continue until their term ends. The company should maintain compliance until the appointment naturally expires.

Section 8 companies are often exempt from certain provisions, but they must appoint a CS if they meet the Section 203 criteria (listed or ₹10 Crore+ public company). Most Section 8 companies don’t meet these thresholds and are not mandated to appoint a KMP.

Form DIR-12 is filed for all KMP appointments (MD, WTD, Manager, CS, CFO, CEO) within 30 days under Section 170(2). Form MR-1 is additionally filed only for MD, WTD, and Manager within 60 days under Section 196(4). Public companies must also file MGT-14 for Board Resolution within 30 days for MD and Manager appointments.

No. As per the Companies (Appointment and Remuneration of Managerial Personnel) Amendment Rules, 2016 (effective June 30, 2016), CS, CFO, and CEO appointments require only Form DIR-12 filing within 30 days. Form MR-1 applies exclusively to Managing Director, Whole-Time Director, and Manager appointments as per Section 196(4) read with Rule 3.

Yes, Form DIR-12 is mandatory for a Manager appointment within 30 days under Section 170(2). Since the Manager is a KMP under Section 2(51), the appointment must be intimated via DIR-12. Additionally, Form MR-1 must also be filed within 60 days, as the Manager is covered under Section 196(4) alongside MD and WTD.

• For Public Companies: MD/WTD/Manager appointment requires Board approval plus shareholder approval at the next General Meeting under Section 196. For CS and CFO, Board approval is sufficient.
• For Private Companies: Board approval alone suffices for all KMP positions as per MCA Notification dated 05.06.2015.

As per Section 178, the NRC (mandatory for listed and certain public companies) identifies qualified candidates, recommends them to the Board, and formulates remuneration policy for KMP. The NRC ensures transparent, merit-based selection of leadership.

As per Section 203(1), an individual cannot act as both Chairperson and MD/CEO simultaneously unless the Articles of Association permit it, or the company operates a single business. Listed companies with multiple businesses must have separate persons.

A whole-time KMP cannot hold office in another company except its subsidiary as per Section 203(3). However, they can be a Director in other companies with Board permission. A person can be the MD of a maximum of two companies with unanimous Board consent.

As per Section 196(2), the tenure for MD, WTD, or Manager cannot exceed 5 years at a time. Re-appointment is permitted but not earlier than one year before the expiry of the current term. Early re-appointment requires compliance with Schedule V.

As per Section 196(3) read with Schedule V, the appointee must be between 21 and 70 years old. Appointment of a person above 70 years requires a Special Resolution by shareholders explaining the justification for such appointment.

Yes, a company can have more than one MD if the Articles of Association allow it. The roles, responsibilities, and powers of each MD must be clearly defined in the appointment agreement. Each MD must comply with all provisions individually.

As per Section 203(4), any vacancy in the office of a whole-time KMP must be filled by the Board at a Board Meeting within 6 months from the date of such vacancy. The vacancy cannot be filled by a circulation resolution.

Yes, a KMP can resign by giving notice to the company. The Board must take note of the resignation at a Board Meeting. The company must file Form DIR-12 for cessation within 30 days of the resignation becoming effective.

Paid-up capital is calculated based on the latest audited balance sheet. If capital increases during the financial year to ₹10 Crore or more, the company must appoint the required KMP within 6 months from the date of such increase.

Yes, but if remuneration exceeds prescribed limits, the appointment must comply with Section 188 (Related Party Transactions). Prior Board approval and disclosure in Form MBP-1 are required. Shareholders’ approval may be needed in certain cases.

Directors and the Company Secretary need a Class 3 DSC to sign statutory forms on the MCA portal. CFO may also need DSC if authorised to sign forms. KMPs who are not directors may not require DSC unless specifically authorised for MCA filings.

Yes, as per Section 2(24) read with Section 2(1)(c) of the Company Secretaries Act, 1980, a person appointed as Company Secretary KMP must be a member of the Institute of Company Secretaries of India (ICSI). This ensures professional qualification.

Yes, a Director can be designated as Chief Financial Officer. They would hold dual positions – Director and CFO (Whole-Time KMP). They must comply with all provisions applicable to both roles, including disclosure requirements and restrictions.

Yes, a CEO need not be a Director of the company. The CEO is a KMP position designated by the Board to manage the company’s strategic direction. However, in practice, many companies appoint their CEO as a Director for better governance.

As per Section 92(1), the Company Secretary signs the Annual Return (Form MGT-7). If there is no CS, a Director authorised by the Board signs it. For companies requiring CS certification, a Practising Company Secretary also certifies the return.

Setindiabiz handles the entire KMP appointment lifecycle: eligibility verification, drafting Board Resolutions and appointment letters, obtaining required consents (DIR-2, MBP-1, DIR-8), and filing Forms DIR-12, MR-1, and MGT-14 with ROC for 100% statutory compliance.